Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2023 · 10-Q
Revenue$15.75M$15.75M+62.9% vs Q2 2022 Net Income-$1.83M-$1.83MN/M vs Q2 2022 EPS Diluted-$0.22-$0.22N/M vs Q2 2022 Gross Profit$13,565,648+55.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,719,849N/M Free Cash Flowderived-$1,732,794N/M Margins · derivedGross margin86.1%−4.0 pt vs Q2 2022
Operating margin-11.8%+23.2 pt vs Q2 2022
Net margin-11.6%−19.6 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end